Corvus Pharma Stock (NASDAQ: CRVS) stock price, news, charts, stock research, profile.
Open | $2.65 |
Close | $2.57 |
Volume / Avg. | 108.58K / 231.96K |
Day Range | 2.51 - 2.69 |
52 Wk Range | 1.05 - 3.00 |
Market Cap | $167.56M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 63 |
Short Interest | 2.49% |
Days to Cover | 10.54 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Corvus Pharma (NASDAQ:CRVS) through any online brokerage.
Other companies in Corvus Pharma’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Outlook Therapeutics (NASDAQ:OTLK), Skye Bioscience (NASDAQ:SKYE), Innate Pharma (NASDAQ:IPHA) and Galectin Therapeutics (NASDAQ:GALT).
There is no analysis for Corvus Pharma.
Corvus Pharma has a consensus price target of $6.83.
The stock price for Corvus Pharma (NASDAQ: CRVS) is $2.6787 last updated July 30, 2024 at 6:24 PM EDT.
There are no upcoming dividends for Corvus Pharma.
Corvus Pharma’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Corvus Pharma.
Corvus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.